ANTIBE THERAPEUTICS INCANTIBE THERAPEUTICS INCANTIBE THERAPEUTICS INC

ANTIBE THERAPEUTICS INC

No trades
See on Supercharts

Price target

2.000.00 0.00%
The 2 analysts offering 1 year price forecasts for ATE have a max estimate of — and a min estimate of —.

Analyst rating

Based on 2 analysts giving stock ratings to ATE in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions

ATE EPS for the last quarter is −0.08 CAD despite the estimation of −0.11 CAD. In the next quarter EPS is expected to reach −0.09 CAD. Track more of ANTIBE THERAPEUTICS INC financials and stay on top of what is up with the company.
According to analysts, ATE price target is 2.00 CAD with a max estimate of 2.00 CAD and a min estimate of 2.00 CAD. Check if this forecast comes true in a year, meanwhile keep track of the current situation with ATE news and stock market news.